About five minutes after Illumina announced their intention to acquire PacBio, my phone started ringing with market analysts, fund managers, and journalists all looking for the answer to one question: Will this merger pass anti-trust review? While I can’t say whether it WILL, I can emphatically say that it SHOULD. Read on to see why...
Every so often someone will ask about the various “generations” of DNA sequencing or a company will claim to have the latest generation – 3rd, 4th, even “last”. (Hey, Genia, if you don’t come out with something soon, I’m going to start calling your platform “late” generation sequencing – as in “late to the party”...
Helix, the DTC genomics company Illumina spun out in 2015, is open and ready for business. They have used their initial $100M investment to establish a marketplace for the analysis of consumer genomes – an “app store” for genomics, along the lines of Apple’s App Store or Google Play. Helix does the heavy lifting by...